Mario Balsa/X
Jun 29, 2025, 06:30
Mario Balsa Shared an Article on HER2 Alterations in Non-Small Cell Lung Cancer
Mario Balsa, Medical Oncology resident at ICO, shared a post on X:
“New in Frontiers – Oncology by Aakash Desai, Ahmed Ismail and Yanis Boumber.
HER2-Altered NSCLC: From Research to Therapeutic Targets
Love it!! But…can HER2 keep dancing when resistance cuts the music?”
Title: HER2 alterations in non-small cell lung cancer (NSCLC): from biology and testing to advances in treatment modalities
Authors: Aakash Desai, Ahmed Ismail and Yanis Boumber
You can read the Full Article on Frontiers – Oncology
More posts featuring NSCLC.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 19, 2025, 02:39
Jul 18, 2025, 21:36
Jul 18, 2025, 21:35
Jul 18, 2025, 19:26
Jul 18, 2025, 19:23
Jul 18, 2025, 18:53